Cardiac allograft vasculopathy optical coherence tomography

Cardiac allograft vasculopathy Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Differentiating Cardiac allograft vasculopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Coronary Angiography
Intravascular Ultrasound
Optical Coherence Tomography
CT
MRI
Echocardiography
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cardiac allograft vasculopathy optical coherence tomography On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cardiac allograft vasculopathy optical coherence tomography All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cardiac allograft vasculopathy optical coherence tomography
CDC on Cardiac allograft vasculopathy optical coherence tomography
Cardiac allograft vasculopathy optical coherence tomography in the news
Blogs on Cardiac allograft vasculopathy optical coherence tomography
Directions to Hospitals Treating Cardiac allograft vasculopathy
Risk calculators and risk factors for Cardiac allograft vasculopathy optical coherence tomography

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]

Overview

In 2010, U.S FDA approved coronary optical cohorence tomography (OCT) as a new catheter based intra-vascular imaging modality with a resolution higher than intravascular ultrasound (IVUS). OCT uses near infra-red light and constructs images from the reflected light which is in the same phase (i.e cohorent) with the emitted light. This eliminated the interference from scattered light, thereby producing images with higher resolution.

Coronary Optical Cohorence Tomography

Advantages

• Allows rapid imaging of coronaries with a higher radial resolution.
• Detects more subtle changes in the intima-media thickness compared to IVUS in patients with early CAV.
• Accurate plaque characterization.

Limitations

• Complete blood washout from the coronaries is necessary to obtain good quality images.
• Deep tissue penetration is not as good as IVUS.